| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |